[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE73663T1 - Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten. - Google Patents

Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten.

Info

Publication number
ATE73663T1
ATE73663T1 AT86105776T AT86105776T ATE73663T1 AT E73663 T1 ATE73663 T1 AT E73663T1 AT 86105776 T AT86105776 T AT 86105776T AT 86105776 T AT86105776 T AT 86105776T AT E73663 T1 ATE73663 T1 AT E73663T1
Authority
AT
Austria
Prior art keywords
phosphonylmethoxyalkyl
adenines
treatment
virus diseases
virus
Prior art date
Application number
AT86105776T
Other languages
English (en)
Inventor
Clercq Erik De
Antonin Holy
Ivan Rosenberg
Original Assignee
Stichting Rega V Z W
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega V Z W, Ceskoslovenska Akademie Ved filed Critical Stichting Rega V Z W
Application granted granted Critical
Publication of ATE73663T1 publication Critical patent/ATE73663T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT86105776T 1985-04-25 1986-04-25 Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten. ATE73663T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS853018A CS263952B1 (en) 1985-04-25 1985-04-25 Remedy with antiviral effect
EP86105776A EP0205826B1 (de) 1985-04-25 1986-04-25 Phosphonylmethoxyalkyl-Adeninen zur Behandlung von Viruskrankheiten

Publications (1)

Publication Number Publication Date
ATE73663T1 true ATE73663T1 (de) 1992-04-15

Family

ID=5369042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86105776T ATE73663T1 (de) 1985-04-25 1986-04-25 Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten.

Country Status (17)

Country Link
US (1) US4724233A (de)
EP (1) EP0205826B1 (de)
JP (1) JPH0692307B2 (de)
AT (1) ATE73663T1 (de)
AU (1) AU586860B2 (de)
CA (1) CA1272956A (de)
CS (1) CS263952B1 (de)
DE (1) DE3684363D1 (de)
DK (1) DK167342B1 (de)
EG (1) EG18436A (de)
GR (1) GR861089B (de)
HK (1) HK217296A (de)
IL (1) IL78553A (de)
NZ (1) NZ215939A (de)
PH (1) PH23112A (de)
PT (1) PT82457B (de)
ZA (1) ZA863133B (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
US5650510A (en) * 1986-11-18 1997-07-22 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
AU613592B2 (en) * 1986-11-18 1991-08-08 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosophonomethoxy-alkyene purine and pyrimide derivatives
US5284837A (en) * 1988-05-06 1994-02-08 Medivir Ab Derivatives of purine, process for their preparation and a pharmaceutical preparation
EP0353955A3 (de) * 1988-08-02 1991-08-14 Beecham Group Plc Chemische Verbindungen
US5688778A (en) * 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs
US5302585A (en) * 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
ATE167679T1 (de) * 1990-09-14 1998-07-15 Acad Of Science Czech Republic Wirkstoffvorläufer von phosphonaten
DE69218968T2 (de) * 1991-10-11 1997-10-09 Inst Of Organic Chemistry And Antivirale acyclische phosphonomethoxyalkyl substituierte, alkenyl und alkynyl purin und pyrimidin-derivate
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
US5514798A (en) * 1993-06-02 1996-05-07 Gilead Sciences, Inc. Method and cyclic carbonates for nucleotide analogues
CA2171868A1 (en) * 1993-09-17 1995-03-23 Petr Alexander Method for dosing therapeutic compounds
US5798340A (en) * 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5468752A (en) * 1994-04-04 1995-11-21 Freeman; William R. Treatment of conditions of abnormally increased intraocular pressure by administration of HPMPC and related phosphonylmethoxyalkylcytosines
WO1995026734A1 (en) * 1994-04-04 1995-10-12 Freeman William R Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
TWI230618B (en) * 1998-12-15 2005-04-11 Gilead Sciences Inc Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
US6635278B1 (en) 1998-12-15 2003-10-21 Gilead Sciences, Inc. Pharmaceutical formulations
US7205404B1 (en) 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
JP2003519232A (ja) * 2000-01-07 2003-06-17 ウニフェルジテーレ・インステリング・アントウェルペン プリン誘導体、その製造法およびその使用
EP1301519B2 (de) 2000-07-21 2021-11-10 Gilead Sciences, Inc. Prodrugs von phosphonat-nukleotidanalogen und verfahren für das auswählen und die herstellung derselben
AU2002315625B2 (en) * 2001-06-29 2008-05-01 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic 6-2'-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity
EP2223927B1 (de) * 2002-05-13 2014-10-15 Metabasis Therapeutics, Inc. Salze einer auf Phosphonsäure basierenden Prodrug von PMEA
WO2003095665A2 (en) * 2002-05-13 2003-11-20 Metabasis Therapeutics, Inc. Pmea and pmpa cyclic producing synthesis
GB2413556B (en) * 2002-11-12 2007-03-14 Tianjin Kinsly Pharmaceutical A new crystal form of adefovir dipivoxil and its composition
AP2089A (en) 2003-01-14 2010-01-11 Gilead Sciences Inc Compositions and methods for combination antiviraltherapy
WO2004111064A1 (en) 2003-06-16 2004-12-23 Institute Of Organic Chemistry And Biochemistry, Academy Of Sciences Of The Czech Republic Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
EP1753762B1 (de) * 2004-06-08 2014-03-19 Metabasis Therapeutics, Inc. Lewissäurevermittelte synthese von cyclischen estern
CN100338080C (zh) * 2004-06-16 2007-09-19 山东中科泰斗化学有限公司 9－[2－(膦羧基甲氧基)乙基]腺嘌呤双环醇酯及其制备方法
PL1778251T3 (pl) 2004-07-27 2011-09-30 Gilead Sciences Inc Koniugaty fosfonianowo-nukleozydowe jako środki przeciw wirusowi HIV
WO2006066074A2 (en) * 2004-12-16 2006-06-22 The Regents Of The University Of California Lung-targeted drugs
US20090156545A1 (en) * 2005-04-01 2009-06-18 Hostetler Karl Y Substituted Phosphate Esters of Nucleoside Phosphonates
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
FR2908133B1 (fr) 2006-11-08 2012-12-14 Centre Nat Rech Scient Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
PL2514750T3 (pl) 2007-06-18 2014-05-30 Ruyuan Wei Xiang Tech Co Ltd Tiazolilodihydropirymidyny podstawione bromofenylem
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
US7935817B2 (en) * 2008-03-31 2011-05-03 Apotex Pharmachem Inc. Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
TWI557117B (zh) 2008-12-09 2016-11-11 吉李德科學股份有限公司 用於製備可用作類鐸受體調節劑之化合物的中間體化合物
WO2010110622A2 (en) 2009-03-26 2010-09-30 Daewoong Pharmaceutical Co., Ltd. Novel crystal forms of adefovir dipivoxil and processes for preparing the same
US20110223131A1 (en) 2010-02-24 2011-09-15 Gilead Sciences, Inc. Antiviral compounds
CA2819548C (en) 2010-12-10 2019-04-09 Sigmapharm Laboratories, Llc Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
AU2014228321C1 (en) 2013-03-15 2019-07-11 The Regents Of The University Of California Acyclic nucleoside phosphonate diesters
WO2015038421A1 (en) 2013-09-10 2015-03-19 Dow Corning Corporation Wear-resistant silicon eutectic alloy components and methods of making the same
CA2937548C (en) 2014-02-13 2022-10-25 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
WO2015195538A1 (en) 2014-06-17 2015-12-23 Dow Corning Corporation Decorative shape-cast articles made from silicon eutectic alloys, and methods for producing the same
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
JP6522732B2 (ja) 2014-07-11 2019-05-29 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖを治療するためのトール様受容体の調節因子
DK3194411T3 (da) 2014-09-15 2022-05-30 Univ California Nukleotidanaloger
EP3875462A1 (de) 2015-09-15 2021-09-08 The Regents of The University of California Nukleotidanaloga
AU2016322763A1 (en) 2015-09-15 2018-04-19 Gilead Sciences, Inc. Modulators of toll-like recptors for the treatment of HIV
EP3372227A1 (de) 2017-03-06 2018-09-12 MH10 Spolka z ograniczona odpowiedzialnoscia Tablettenformulierung von adefovir dipivoxil
CN111788196A (zh) 2018-01-09 2020-10-16 配体药物公司 缩醛化合物及其治疗用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
JPS52105195A (en) * 1976-03-01 1977-09-03 Wellcome Found Substituted purine
US4230708A (en) * 1977-10-20 1980-10-28 Stichting Rega V.Z.W. Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CS238038B1 (en) * 1983-10-07 1985-11-13 Antonin Holy Medical drug with antivirus effect

Also Published As

Publication number Publication date
DK167342B1 (da) 1993-10-18
ZA863133B (en) 1987-02-25
DK184186D0 (da) 1986-04-22
JPH0692307B2 (ja) 1994-11-16
US4724233A (en) 1988-02-09
JPS61275218A (ja) 1986-12-05
EG18436A (en) 1993-02-28
DE3684363D1 (de) 1992-04-23
DK184186A (da) 1986-10-26
EP0205826A2 (de) 1986-12-30
NZ215939A (en) 1988-09-29
EP0205826B1 (de) 1992-03-18
GR861089B (en) 1986-08-26
HK217296A (en) 1996-12-27
PH23112A (en) 1989-04-19
EP0205826A3 (en) 1989-05-10
IL78553A (en) 1989-09-28
CS263952B1 (en) 1989-05-12
CA1272956A (en) 1990-08-21
AU5646886A (en) 1986-10-30
AU586860B2 (en) 1989-07-27
IL78553A0 (en) 1986-08-31
PT82457B (pt) 1988-03-03
PT82457A (en) 1986-05-01

Similar Documents

Publication Publication Date Title
ATE73663T1 (de) Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten.
DE58906894D1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
DE3678900D1 (de) Vorrichtung zur kontinuierlichen behandlung von viskosem material.
AT372600B (de) Vorrichtung zur abgabe von pflegemittel an aerztliche, insbesondere zahnaerztliche handstuecke
DK62089A (da) Antiviral blanding
DE68912020D1 (de) N-2,3-Butadienyl-tri-aminoalkanderivate.
ATE74762T1 (de) Pharmazeutisches praeparat zur behandlung von stoerungen des fettstoffwechsels (hyperlipoproteinaemien).
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
FI881123A (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
DE68909750D1 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
DE3462891D1 (en) New pyrimidine derivatives endowed with antiviral activity
DE3668778D1 (de) Vorrichtung zur laserchirurgie und insbesondere zur keratotomie der cornea (iii).
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.
DE3883754D1 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
DE69118847D1 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
DE3687895D1 (de) Arginin- und agmatinderivate zur behandlung von protozoen-infektionen.
ATE81587T1 (de) Medizinisches praeparat zur behandlung von hautleiden.
ATE44481T1 (de) Vorrichtung zur behandlung von werkstuecken.
ATE101054T1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.
ATE95414T1 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time